https://academic.oup.com/hmg/advance-article/doi/10.1093/hmg/ddz026/5308640
https://www.ncbi.nlm.nih.gov/pubmed/30753450
HDAC Inhibitors Rescue Multiple Disease-Causing CFTR Variants.
These data suggest that HDACi can serve to level the cellular playing field for correcting CF-causing mutations, a leveling effect that might also extend to other protein misfolding diseases.
